TeraFlu LAR, spray 30 ml

TheraFlu LAR has antiseptic, anti-inflammatory effect.

Pharmacodynamics

Benzoxonium chloride is a salt of quaternary ammonium: N-benzyl-N-dodecyl N,N-di (2-hydroxyethyl) ammonium chloride. Due to its cationic structure it has membranotropic activity and has a pronounced antibacterial effect on Gram-positive and, to a lesser extent, on Gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses).

Lidocaine is a local anesthetic which reduces soreness in the throat when swallowing in inflammatory processes.

Pharmacokinetics

Benzoxonium chloride is practically not absorbed. Approximately 1% of the administered dose is detected in the urine; the concentration of the substance in the blood is practically undetectable. No accumulation of the substance in body tissues has been detected.

Lidocaine is absorbed by oral administration and through the oral mucosa. It is metabolized during the first passage through the liver, with a bioavailability of approximately 35% when administered orally. Metabolites are excreted with the urine, less than 10% of the substance is excreted unchanged.

Indications

Infectious inflammatory diseases of the mouth and throat:

Composition

1 ml contains:

The active ingredients:

benzoxonium chloride 2 mg,

lidocaine hydrochloride 1.5 mg;

Excipients:

ethanol,

peppermint oil,

menthol,

glycerol,

hydrochloric acid,

purified water.

How to take, the dosage

TheraFlu LAR is used topically.

Spray solution: spray in the oral cavity holding the can upright.

Adults: 4 sprays (approximately 0.5 ml) 3-6 times a day.

Children 4 years of age and older: 1 to 2 to 3 sprays 3 to 6 times a day.

Duration of treatment is not more than 5 days.

If there is no relief of symptoms within 5 days of therapy, the patient should see a doctor.

Special Instructions

Alcohol should be avoided during use of TeraFlu LAR.

Contraindications

Hypersensitivity to lidocaine or ammonia compounds.

Side effects

Possible local irritation; reversible brown staining of tongue and teeth if used for more than 2 weeks.

Pregnancy use

The drug is contraindicated in the first trimester of pregnancy and during lactation (breast-feeding).

Inadequate and strictly controlled clinical safety studies of the drug during pregnancy have not been conducted. It is not recommended to use the drug in the second and third trimesters.

There are no clinical data on excretion of the active substances with the breast milk. Nevertheless, the drug is not recommended to use during breast-feeding.

In experimental studies no effect of the drug on reproduction and fetal development was found.

Contraindicated: children under 4 years of age.